Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bobo WV"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Treatment outcomes of acute bipolar depressive episode with psychosis.
    Autorzy:
    Caldieraro MA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Serviço de Psiquiatria, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brasil.
    Dufour S; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
    Sylvia LG; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
    Gao K; Mood Disorders Program, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
    Ketter TA; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA.
    Bobo WV; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
    Walsh S; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
    Janos J; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
    Tohen M; Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
    Reilly-Harrington NA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
    McElroy SL; Lindner Center of HOPE, Mason, OH, USA.; Deparment of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
    Shelton RC; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
    Bowden CL; Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX, USA.
    Deckersbach T; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
    Nierenberg AA; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
    Pokaż więcej
    Źródło:
    Depression and anxiety [Depress Anxiety] 2018 May; Vol. 35 (5), pp. 402-410. Date of Electronic Publication: 2018 Jan 12.
    Typ publikacji:
    Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
    MeSH Terms:
    Bipolar Disorder*/drug therapy
    Bipolar Disorder*/epidemiology
    Bipolar Disorder*/physiopathology
    Psychotic Disorders*/drug therapy
    Psychotic Disorders*/epidemiology
    Psychotic Disorders*/physiopathology
    Treatment Outcome*
    Antimanic Agents/*pharmacology
    Antipsychotic Agents/*pharmacology
    Lithium Compounds/*pharmacology
    Quetiapine Fumarate/*pharmacology
    Adult ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Association between history of psychosis and cardiovascular disease in bipolar disorder.
    Autorzy:
    Prieto ML; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Rochester, MN, USA.; Departamento de Psiquiatría, Facultad de Medicina, Universidad de los Andes, Santiago, Chile.
    McElroy SL; Lindner Center of HOPE, Mason, OH, USA.; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
    Hayes SN; Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
    Sutor B; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Rochester, MN, USA.
    Kung S; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Rochester, MN, USA.
    Bobo WV; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Rochester, MN, USA.
    Fuentes ME; Department of Psychiatry, Facultad de Medicina Clínica Alemana/Universidad del Desarrollo, Santiago, Chile.
    Cuellar-Barboza AB; Department of Psychiatry, Universidad Autónoma de Nuevo León, Monterrey, México.
    Crow S; Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA.
    Ösby U; Department of Psychiatry, Karolinska Institutet, Stockholm, Sweden.
    Chauhan M; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Rochester, MN, USA.
    Westman J; Department of Psychiatry, Karolinska Institutet, Stockholm, Sweden.
    Geske JR; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
    Colby CL; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
    Ryu E; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
    Biernacka JM; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Rochester, MN, USA.; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
    Frye MA; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Rochester, MN, USA.
    Pokaż więcej
    Źródło:
    Bipolar disorders [Bipolar Disord] 2015 Aug; Vol. 17 (5), pp. 518-27. Date of Electronic Publication: 2015 Jun 09.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Bipolar Disorder/*epidemiology
    Cardiovascular Diseases/*epidemiology
    Psychotic Disorders/*epidemiology
    Adult ; Age Factors ; Aged ; Bipolar Disorder/classification ; Bipolar Disorder/psychology ; Comorbidity ; Cross-Sectional Studies ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Humans ; Hypertension/epidemiology ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Psychotic Disorders/psychology ; Severity of Illness Index
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia.
    Autorzy:
    Bonaccorso S; Department of Psychosis Studies, Institute of Psychiatry at the Maudsley, King's College London, London, UK.
    Sodhi M; Department of Pharmacy Practice, University of Illinois, Chicago, IL, USA.
    Li J; Department of Psychiatry and Behavioural Sciences, Northwestern University, Chicago, IL, USA.
    Bobo WV; Mayo Clinic, Rochester, MN, USA.
    Chen Y; Southern Arizona VA Health Care System, Tucson, AZ, USA.
    Tumuklu M; Faculty of Medicine, Department of Psychiatry, Gaziosmanpasa University, Tokat, Turkey.
    Theleritis C; Department of Psychosis Studies, Institute of Psychiatry at the Maudsley, King's College London, London, UK.
    Jayathilake K; Department of Psychiatry and Behavioural Sciences, Northwestern University, Chicago, IL, USA.
    Meltzer HY; Department of Psychiatry and Behavioural Sciences, Northwestern University, Chicago, IL, USA.
    Pokaż więcej
    Źródło:
    Bipolar disorders [Bipolar Disord] 2015 Aug; Vol. 17 (5), pp. 528-35. Date of Electronic Publication: 2015 Apr 15.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antipsychotic Agents/*adverse effects
    Bipolar Disorder/*drug therapy
    Brain-Derived Neurotrophic Factor/*genetics
    Insulin Resistance/*genetics
    Obesity/*genetics
    Psychotic Disorders/*drug therapy
    Schizophrenia/*drug therapy
    Adult ; Alleles ; Benzodiazepines/adverse effects ; Blood Glucose/metabolism ; Body Mass Index ; Cholesterol, HDL/metabolism ; Cholesterol, LDL/metabolism ; Dyslipidemias/chemically induced ; Dyslipidemias/genetics ; Dyslipidemias/metabolism ; Female ; Genotype ; Glycated Hemoglobin/metabolism ; Humans ; Male ; Middle Aged ; Obesity/chemically induced ; Obesity/metabolism ; Olanzapine ; Polymorphism, Genetic ; Polymorphism, Single Nucleotide ; Prospective Studies ; Risk Factors ; Risperidone/adverse effects ; Triglycerides/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Converting from brand-name to generic clozapine: a review of effectiveness and tolerability data.
    Autorzy:
    Bobo WV; Department of Psychiatry, School of Medicine, Vanderbilt University, 1601 23rd Avenue South, Suite 3035, Nashville, TN 37212, USA. william.v.bobo@vanderbilt.edu
    Stovall JA
    Knostman M
    Koestner J
    Shelton RC
    Pokaż więcej
    Źródło:
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2010 Jan 01; Vol. 67 (1), pp. 27-37.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Antipsychotic Agents/*therapeutic use
    Clozapine/*therapeutic use
    Drugs, Generic/*therapeutic use
    Psychotic Disorders/*drug therapy
    Antipsychotic Agents/adverse effects ; Antipsychotic Agents/pharmacokinetics ; Clozapine/adverse effects ; Clozapine/pharmacokinetics ; Drugs, Generic/adverse effects ; Drugs, Generic/pharmacokinetics ; Humans ; Therapeutic Equivalency
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies